Paracoccidioidomycosis (PCM) is an endemic and systemic mycosis recognised as a public health problem throughout Latin America, especially in Brazil, Colombia, Venezuela and Argentina ([@B33], [@B07]). The infection is caused by the inhalation of *Paracoccidioides brasiliensis* conidia, which usually causes a benign and transient pulmonary infection. In 90% of clinically active cases, PCM develops into a chronic, systemic and progressive disease that usually affects adult male farmers, while 10% of cases involving the clinically active form of PCM are reported as acute (or juvenile) infections. The lung is the primary infection site, but dissemination occurs regularly, with the appearance of secondary lesions in other organs and systems ([@B03], [@B31]).

As in other fungal infections (e.g., histoplasmosis, cryptococcosis, coccidioidomycosis and blastomycosis) ([@B16]), the mechanisms used by this fungal pathogen to cause infection and dissemination in the host are unclear, but during the initial interaction of *P. brasiliensis* conidia with host tissue components, both extracellular matrix (ECM) proteins and epithelial/endothelial cells are most likely involved ([@B22], [@B05], Gonzalez et al. 2008a). These interactions could also participate in the dissemination process. Nonetheless, various *P. brasiliensis* virulence factors have been described, such as extracellular enzymes capable of degrading host molecules ([@B28]) and ECM component-binding molecules, including fibrinogen, fibronectin and laminin ([@B12]).

The interaction of microorganisms with host components, including ECM proteins and cells, is an important mechanism that allows invasion, establishment, proliferation, tropism and immune response modulation. Moreover, amplification of the immune response could result in the activation of both coagulation system pathways, i.e., the "extrinsic", which depends on the release of tissue factor and the "intrinsic *"* (also known as the contact system) ([@B25]). During the infectious process, the intrinsic pathway is involved in regulating pro-inflammatory activity, host defence and disease severity. Several pathogens express molecules that interact with fibrinogen and plasminogen, the former considered the major plasma protein coagulation factor ([@B23], [@B01], [@B25]).

Fibrinogen is a key component of the coagulation system and is also found in the ECM of damaged tissue. This plasma glycoprotein controls blood loss during tissue damage ([@B14], [@B09]). Fibrinogen is converted to fibrin by the action of thrombin during the coagulation cascade process, which appears to be important for pathogen containment; however, several microorganisms can overcome this process. In addition, the fibrinogen/fibrin deposits produced during the inflammatory process can be used by the pathogens to adhere to the mucosal surface ( [@B37], [@B36], [@B10], [@B26]). In our pulmonary PCM murine model, infected animals show increased ECM protein expression (mainly fibrinogen, fibronectin and laminin) in the lungs during the acute phase of infection (Gonzalez et al. 2008b). In addition, fibrinogen inhibits the adherence and internalisation of *P. brasiliensis* conidia in alveolar type II cells ([@B05], Gonzalez et al. 2008a). This finding suggests a role for fibrinogen in fungal adherence to host tissues. All of the above reports suggest that both the adhesion and aggregation processes could be important in PCM pathogenesis.

In the present study, we evaluated the ability of *P. brasiliensis* conidia to aggregate with fibrinogen, as well as with different molecules involved in the coagulation system and other compounds present in human plasma. We also investigated the ability of the fungus to activate the coagulation system. The results of these aggregation assays indicate that fibrinogen and other proteins are involved in the interaction of *P. brasiliensis* conidia with the coagulation system. Moreover, incubation of *P. brasiliensis* conidia with human plasma resulted in the prolongation of the time needed to activate the intrinsic coagulation pathway. These interactions may play an important role in the initial inflammatory response, as well as in the progression of the fungal disease caused by *P. brasiliensis* dissemination.

SUBJECTS, MATERIALS AND METHODS
===============================

*Fungal growth and conidia production* - The *P. brasiliensis* isolate we used was ATCC 60855, which sporulates freely on water-agar (Bacto-agar DIFCO, Detroit, MI, USA). The procedures for growing mycelia in a chemically defined medium and for collecting and dislodging conidia were performed as reported previously ([@B32], [@B34]). The conidia were counted in a haemocytometer and their viability was determined using fluorescein diacetate and ethidium bromide staining ([@B04]).

*Reagents* - The bovine fibrinogen, human fibronectin, immunochemicals and reagents employed in this study were obtained from Sigma Chemical Co (Poole, Dorset, UK), unless otherwise specified. In addition, a monoclonal antibody (mAb2G4) against the 32-kDa protein from *P. brasiliensis* was produced as previously described ([@B12]) and was used to treat the conidia suspension. A mouse isotype IgG1 was used as the control at a dilution of 1:100 ([Table](#t01){ref-type="table"}).

TABLECompounds used in *Paracoccidioides brasiliensis* conidia aggregation assaysGroupCompoundConcentrationExtracellular matrix proteinsFibrinogen500 μg/mLFibronectin500 μg/mLMetabolic inhibitorsThimerosal0.02%Cycloheximide10 μg/mLSodium azide1 mMMonosaccharidesN-acetylneuraminic acid200 mMGlucose200 mMGlucosamine200 mMGlycosaminoglycansDextran sulphate10 μg/mLAnticoagulantsHeparin1 UI/mLH-D-Pro-Phe-Arg-chloromethyl ketone50 μg/mLSerine protease inhibitorsLeupeptin10 mMPhenylmethylsulphonyl fluoride50 μg/mLAprotinin50 μg/mLAntibodiesRat IgG control1:100 dilutionMonoclonal antibody against Hid, 32 kDa1:100 dilutionProtein-folding inhibitorCongo red30 μM

*Plasma and serum sources* - Blood samples were drawn from healthy volunteers (n = 6) into Vacutainer tubes (Becton-Dickinson) either without anticoagulants or with 1:9 volumes of 129 mM sodium citrate, pH 7.4, to obtain serum or plasma, respectively. Blood was centrifuged at 2,500 *g* for 15 min. The pellet was removed and the serum and plasma samples were stored at -20°C.

*Aggregation assays* - To evaluate the ability of *P. brasiliensis* conidia to aggregate and the mechanism involved in this aggregation process, 10 ^7^ conidia were re-suspended in 250 µL of phosphate buffered saline (PBS), human serum or plasma and incubated for 3 h at 37°C. A number of different compounds, including EMC proteins (fibrinogen and fibronectin), metabolic inhibitors, monosaccharides, glycosaminoglycans, anticoagulants, serine protease inhibitors and protein folding inhibitors were also added, as detailed in Table. After incubation, conidia were washed three times with PBS and counted in a haemocytometer. The aggregation percentage was established according to the free conidia number in comparison with initial inoculum.

*Clotting assays* - Clotting time was measured in a coagulometer (Coag-A-Mate^®^ XM, Organon Teknika, Durham, USA). Approximately 10 ^7^ *P. brasiliensis* conidia were re-suspended in 250 µL of plasma and incubated for 3 h at 37°C. After incubation, conidia were removed by centrifugation (7,000 *g*, 2 min) and the supernatant filtered using 0.22 µm filters. To investigate the intrinsic coagulation pathway \[activated partial thromboplastin time (aPTT) assay\], 100 µL of reagent APTT (APTT kit, bioMérieux, Inc Durham, NC, USA) was incubated with 100 µL of supernatant for 5 min at 37°C in the coagulometer followed by the addition of 100 µL 25 mM CaCl ~2~ . The extrinsic pathway of coagulation \[prothrombin time (PT) assay\] was studied by adding 200 µL of Simplastin Excel S (bioMérieux) to 100 µL supernatant in the coagulometer at 37°C and the clot-forming time was measured.

*Statistical analysis* - The results are expressed as the mean ± standard error of the means of three independent experiments. The data were analysed by ANOVA and Student's *t* test using GraphPad Prism, version 4.0 for Macintosh (GraphPad Software, San Diego, California, USA). Values of p \< 0.05 were considered statistically significant.

RESULTS
=======

*Human plasma and serum induce P. brasiliensis conidia aggregation* - To determine if the proteins present in both human plasma and serum could induce *P. brasiliensis* conidia aggregation, we incubated fungal propagules with plasma or serum as described in the Subjects, Materials and Methods section. We observed that both human serum and plasma induced conidial aggregation, with plasma inducing the higher aggregation and PBS treatment resulting in minimal aggregation ([Fig. 1A, B](#f01){ref-type="fig"}). We subsequently used human plasma to determine the effects of several compounds involved in the coagulation system.

Fig. 1*Paracoccidioides brasiliensis* conidial aggregation induced by plasma and serum is enhanced by extracellular matrix proteins. Microscopic evaluation of *P. brasiliensis* conidial aggregation in the presence of phosphate buffered saline (PBS) (A) or human plasma (B). Arrows in A indicate free conidia and arrow in B indicates conidial aggregation. Magnifications: 100X. C: *P. brasiliensis* conidial aggregation determined by incubating fungal propagules with human plasma or serum in presence or absence of soluble proteins \[fibrinogen (FG) and fibronectin (FN)\]. Fungal cells were counted with a haemocytometer and the aggregation percentage established according to the free conidia number in comparison to initial inocula. Results expressed as mean ± standard error of the means of three independent experiments. & *:* p \< 0.001 when compared to PBS; *\** : p \< 0.001 when compared to serum; *+* : p \< 0.001 when compared to plasma.

*ECM proteins and carbohydrates enhance conidial aggregation capability* - As observed in [Fig. 1C](#f01){ref-type="fig"}, the addition of exogenous ECM proteins, such as fibrinogen and fibronectin, increased aggregation when PBS or human plasma and serum were used. Moreover, the addition of monosaccharides, including glucose, glucosamine or N-acetylneuraminic acid, increased aggregation when either plasma or PBS was present ([Fig. 2A](#f02){ref-type="fig"}).

Fig. 2effect of monosaccharides, serine proteases and metabolic inhibitors on *Paracoccidioides brasiliensis* conidial aggregation. *P. brasiliensis* conidial aggregation determined by incubating fungal propagules with human plasma in presence or absence of monosaccharides \[glucose (GLU), glucosamine (Gna) and N-acteyl neuroaminic acid (NANA)\] (A), serine protease inhibitors \[aprotinin (Apr), leupoptin (Leu) and phenylmethylsulfonyl fluoride (PMSF)\] (B) and metabolic inhibitors \[sodium azide (AZ), cicloheximide (CH) and timerosal (TM)\] (C). Fungal propagules counted with a haemocytometer and aggregation percentage established according to the free conidia number in comparison to initial inocula. Results expressed as mean ± standard error of the means of three independent experiments. & *:* p \< 0.001 when compared to phosphate buffered saline (PBS); *+* : p \< 0.001 when compared to plasma; ¥: p \< 0.001; §: p \< 0.05 when compared to plasma.

*Protease inhibitors, metabolic inhibitors, protein-folding inhibitors and anticoagulant compounds decrease conidial aggregation capability* - When either protease inhibitors or metabolic inhibitors \[mainly thimerosal and phenylmethylsulphonyl fluoride (PMSF)\], were added to human plasma, a significant decrease in conidial aggregation was observed ([Fig. 2B, C](#f02){ref-type="fig"}). Moreover, the addition of Congo red (a colorant that alters the secondary structure of proteins) to plasma also decreased conidial aggregation ( [Fig. 3A](#f03){ref-type="fig"}).

Fig. 3effect of a folding protein inhibitor or anticoagulants on *Paracoccidioides brasiliensis* conidial aggregation. *P. brasiliensis* conidial aggregation determined by incubating fungal propagules with human plasma in presence or absence of Congo red (CR) (A), dextran (DEX) (B) and anticoagulants \[heparin (Hep) and H-D-Pro-Phe-Arg-chlo-romethyl ketone (HD-CMK)\] (C). Fungal cells counted with a haemocytometer and aggregation percentage established according to the free conidia number in comparison to initial inocula. Results expressed as the mean ± standard error of the means of three independent experiments. Asterisk means p \< 0.001 when compared to plasma.

The addition of dextran, heparin or the peptide H-D-Pro-Phe-Arg-chloromethyl ketone to plasma (all anticoagulants) significantly decreased the aggregation process (p \< 0.001) ([Fig. 3B, C](#f03){ref-type="fig"}).

No alteration in conidial aggregation was observed when a specific mAb was used against a hydrolase family molecule that recognises fibrinogen and fibronectin and is implicated in the fungal adherence process (data not shown).

*P. brasiliensis conidia alter the intrinsic coagulation pathway*Due to the ability of *P. brasiliensis* conidia to bind fibrinogen and to further investigate the interaction of this fungus with the contact system, the effects of *P. brasiliensis* on both intrinsic (aPTT) and extrinsic (PT) coagulation pathways were examined. We observed that plasma from healthy individuals who were previously subjected to incubation with *P. brasiliensis* conidia showed an altered aPTT, indicating that this fungus affected the intrinsic coagulation pathway. However, the PT was not altered ( [Fig. 4](#f04){ref-type="fig"}).

Fig. 4effect of *Paracoccidioides brasiliensis* conidia (Pbc) on the intrinsic and extrinsic pathways of coagulation. *P. brasiliensis* conidia incubated with human citrated plasma for 3 h at 37°C. Fungal cells removed and resulting plasma supernatants analysed by clot formation assays. Data are representative of experiments using plasma from six different volunteers, each done in duplicate. PT: prothrombin. Asterisk means p \< 0.001 when compared to partial thromboplastin time (PTT) control.

DISCUSSION
==========

Fibrinogen is considered one of the most important plasma proteins in the coagulation and inflammation processes. Fibrin clots produced by the interaction of fibrinogen with thrombin during the activation of the contact system allow for pathogen containment by creating a barrier to the surrounding tissue and preventing invasion and dissemination ([@B17] ). Furthermore, during the establishment of the infectious process, pathogens must overcome many other immune response processes, including activation of the contact system, which results in the initiation of the intrinsic coagulation pathway ([@B35]). Nevertheless, over-activation of the contact system could be deleterious to the host and would be an important factor in the pathogenicity of invading organisms as a consequence of increased vascular permeability, which enables organisms to access and colonise other host tissues. Additionally, the pathogen could activate the contact system and thereby modulate the host immune response for its own benefit ([@B18]), *e.g.*, by the induction of a hypocoagulative state in the infectious focus to avoid entrapment by the fibrin network.

*P. brasiliensis* binds to fibrinogen, an ECM protein overexpressed in the lungs of mice infected with this fungal pathogen; this interaction is mediated by adhesins expressed on its own surface ([@B12], 2008a, b). Additionally, in vitro studies have demonstrated that this fungal pathogen has the ability to degrade ECM proteins, including fibrinogen ([@B28]), an effect that may inhibit or prevent containment of the fungal pathogen by the coagulation system. Thus, the above virulence factors exhibited by *P. brasiliensis* may promote colonisation and widespread dissemination via the circulatory system.

The coagulation system is believed to play an important role in the homeostasis process because it is involved in the response to injurious stimuli and pathogen invaders ([@B06]). Human plasma contains coagulation factors that can stimulate the aggregation process of some microorganisms, including fungal pathogens; this process could facilitate pathogen adhesion to host cells with subsequent tissue invasion ([@B02]). In the present study, *P. brasiliensis* conidia aggregated in the presence of human plasma, suggesting that certain proteins, including fibrinogen and other coagulation factors, may not only facilitate fungal adhesion to the host tissue, but may also initiate the activation of the contact system.

In the aggregation assays, we observed that the addition of exogenous fibrinogen and fibronectin, as well as monosaccharides such as glucose, glucosamine and N-acetylneuraminic acid, enhanced the aggregation process observed with plasma alone. Thus, monosaccharides might have an impact on the binding of plasma proteins to outer membrane-anchored fungal proteins or adhesins present on the fungal surface. However, the addition of thimerosal (a metabolic inhibitor), PMSF (a serine protease inhibitor) or Congo red dye (a protein folding inhibitor) to human plasma significantly diminished conidial adhesion and aggregation. Similar results were reported by [@B30], who expressed the *Candida albicans* adhesin Als5p in *Saccharomyces cerevisiae* to study its effects on adhesion of fungal cells to fibronectin and on cellular aggregation. They observed that fungal cells expressing Alsp5 in the presence of galactose induced adhesion and aggregation, whereas in the presence of agents that perturbed protein secondary structure ( *e.g.,* Congo red), they inhibited the adhesion and aggregation processes. The above results are consistent with the idea that adhesins on the surface of *P. brasiliensis* conidia undergo a conformational shift to form ordered domains on the fungal surface in cellular aggregates and, furthermore, that the conidial aggregation process depends on cellular metabolic activity.

However, medically important fungi have the ability to interact with and activate the coagulation contact system ([@B15], [@B19]). Once activated, the contact system is involved in regulating homeostatic and inflammatory processes ([@B20]). In the present study, *P. brasiliensis* conidia were incubated with human plasma to determine if this fungal pathogen could trigger the coagulation cascade. After incubation, the fungal propagules were removed and the resulting supernatants were analysed in aPTT and PT assays. The conidia of *P. brasiliensis* caused a significant delay in the clotting time for the intrinsic pathway (aPTT), but not the extrinsic pathway (PT). Thus, the binding of fibrinogen and contact factors to *P. brasiliensis* conidia results in the depletion of these proteins in plasma and causes a hypocoagulatory state. Prolongation of clot formation is a sign of deficiency of coagulation factors, indicating less available contact-phase proteins and fibrinogen ([@B27]). These results suggest that *P. brasiliensis* is capable of activating the contact system and that these mechanisms contribute to both the initial adhesion process and dissemination mechanism. More studies are needed to determine whether degradation of fibrinogen or release of other factors is involved in the coagulation process.

Antithrombin (AT) is the major inhibitor of coagulation proteases ([@B29]). A fraction of the circulating AT associates with blood vessel walls by binding to glycosaminoglycans such as dextran sulphate, resulting in its activation ([@B21]). This theory supports our finding that dextran sulphate inhibited *P. brasiliensis* conidia aggregation, most likely by inhibiting coagulation factors. Similar results were observed following the addition of the anticoagulants heparin and H-D-Pro-Phe-Arg-CMK, which resulted in the inhibition of *P. brasiliensis* conidial aggregation. Interestingly, the administration of H-D-Pro-Phe-Arg-CMK to mice infected with *Salmonella* prevents the severe pulmonary lesions caused by this bacterium, suggesting that the inhibition of contact system activation could be used to treat severe infectious diseases ([@B24]).

Adhesin-mediated microbial adherence is a key mechanism in the colonisation, establishment and dissemination of pathogenic fungi ([@B22]). Furthermore, *P. brasiliensis* expresses adhesin molecules on its own surface, allowing adhesion to ECM proteins and host cells ([@B12], 2008a, [@B05], [@B08], [@B19]). One of these molecules is a 32-kDa molecule that belongs to an HAD superfamily that confers to *P. brasiliensis* the capacity to bind to fibrinogen and other ECM proteins ([@B12], 2008a). As described in the Subjects, Materials and Methods section, we used a mAb against this adhesin and we were surprised to observe that *P. brasiliensis* conidial aggregation was not altered by the addition of this antibody (data not shown). This result indicates that the 32-kDa adhesin is not responsible for the *P. brasiliensis* conidial aggregation process and that other molecules on the fungal surface must be involved.

Taken together, these results appear to suggest that *P. brasiliensis* conidia are able to recognise the soluble proteins present in plasma, especially fibrinogen, as well as other factors involved in the coagulation system and these interactions may result in the depletion of plasma proteins, leading to hypocoagulation. The latter may contribute to the pathogenic inflammatory process observed in PCM. These interactions may also be important in adherence to host cells and the subsequent dissemination that occurs in the pathogenesis of PCM. Finally, the above results open the door to exploring the use of coagulation system inhibitors as a novel therapeutic approach to PCM.
